Ahter Dilşad Şanlioğlu

Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells

Ahter Dilşad Şanlioğlu, Ercument Dirice, Nuray Erin et al. · BMC Cancer · 2005 · 124 citations · Full text

Clinical utility of insulin and insulin analogs

Ahter Dilşad Şanlioğlu, Hasan Altunbaş, Mustafa Kemal Balcı et al. · Islets · 2013 · 60 citations · Full text

Insulin Deficiency, Immunology, Insulin Signaling +17

The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma

İsmail Türker Köksal, Ercument Dirice, Duygu Yasar et al. · Urologic Oncology Seminars and Original Investigations · 2004 · 60 citations

Urology, Oncology, Serum Psa +8

TRAIL Death Receptor–4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma

Ahter Dilşad Şanlioğlu, Aylin Fidan Korcum, Elif Peştereli et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 54 citations

Invasive Ductal Carcinoma, Breast Oncology, Oncology +11

DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells

Ahter Dilşad Şanlioğlu, Bahri Karaçay, İsmail Türker Köksal et al. · Cancer Gene Therapy · 2007 · 44 citations

Adenovirus Delivery, Medicine, Prostate Carcinoma Cells +7